| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 9e-05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.22 | 0.0003 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0008 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |